• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

KIR3DS1介导的HLA-*B51识别:自身HLA-B同种异型对KIR3DS1反应性的调节及其对自然杀伤细胞许可的影响

KIR3DS1-Mediated Recognition of HLA-*B51: Modulation of KIR3DS1 Responsiveness by Self HLA-B Allotypes and Effect on NK Cell Licensing.

作者信息

Carlomagno Simona, Falco Michela, Bono Maria, Alicata Claudia, Garbarino Lucia, Mazzocco Michela, Moretta Lorenzo, Moretta Alessandro, Sivori Simona

机构信息

Dipartimento di Medicina Sperimentale, Università degli Studi di Genova, Genova, Italy.

Istituto Giannina Gaslini, Genova, Italy.

出版信息

Front Immunol. 2017 May 26;8:581. doi: 10.3389/fimmu.2017.00581. eCollection 2017.

DOI:10.3389/fimmu.2017.00581
PMID:28603523
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5445109/
Abstract

Several studies described an association between killer-cell immunoglobulin-like receptor (KIR)/HLA gene combinations and clinical outcomes in various diseases. In particular, an important combined role for KIR3DS1 and HLA-B Bw4-I80 in controlling viral infections and a higher protection against leukemic relapses in donor equipped with activating KIRs in haplo-HSCT has been described. Here, we show that KIR3DS1 mediates positive signals upon recognition of HLA-B51 (Bw4-I80) surface molecules on target cells and that this activation occurs only in Bw4-I80 individuals, including those carrying particular KIR/HLA combination settings. In addition, killing of HLA-B51 transfected target cells mediated by KIR3DS1/NKG2A natural killer (NK) cell clones from Bw4-I80 donors could be partially inhibited by antibody-mediated masking of KIR3DS1. Interestingly, KIR3DS1-mediated recognition of HLA-B51 could be better appreciated under experimental conditions in which the function of NKG2D was reduced by mAb-mediated blocking. This experimental approach may mimic the compromised function of NKG2D occurring in certain viral infections. We also show that, in KIR3DS1/NKG2A NK cell clones derived from an HLA-B Bw4-T80 donor carrying 2 gene copy numbers, the positive signal generated by the engagement of KIR3DS1 by HLA-B51 resulted in a more efficient killing of HLA-B*51-transfected target cells. Moreover, in these clones, a direct correlation between KIR3DS1 and NKG2D surface density was detected, while the expression of NKp46 was inversely correlated with that of KIR3DS1. Finally, we analyzed KIR3DS1/NKG2A NK cell clones from a HLA-B Bw4 donor carrying cytoplasmic KIR3DL1. Although these clones expressed lower levels of surface KIR3DS1, they displayed responses comparable to those of NK cell clones derived from HLA-B Bw4 donors that expressed surface KIR3DL1. Altogether these data suggest that, in particular KIR/HLA combinations, KIR3DS1 may play a role in the process of human NK cell education.

摘要

多项研究描述了杀伤细胞免疫球蛋白样受体(KIR)/HLA基因组合与多种疾病临床结局之间的关联。特别是,已描述了KIR3DS1和HLA-B Bw4-I80在控制病毒感染中的重要联合作用,以及在单倍体造血干细胞移植中配备激活型KIR的供体对白血病复发具有更高的保护作用。在此,我们表明KIR3DS1在识别靶细胞上的HLA-B51(Bw4-I80)表面分子时介导阳性信号,并且这种激活仅在Bw4-I80个体中发生,包括那些携带特定KIR/HLA组合的个体。此外,来自Bw4-I80供体的KIR3DS1/NKG2A自然杀伤(NK)细胞克隆介导的对HLA-B51转染靶细胞的杀伤作用可被抗体介导的KIR3DS1封闭部分抑制。有趣的是,在通过单克隆抗体介导的阻断降低NKG2D功能的实验条件下,KIR3DS1介导的对HLA-B51的识别能得到更好的体现。这种实验方法可能模拟了某些病毒感染中发生的NKG2D功能受损。我们还表明,在源自携带2个基因拷贝数的HLA-B Bw4-T80供体的KIR3DS1/NKG2A NK细胞克隆中,HLA-B51与KIR3DS1结合产生的阳性信号导致对HLA-B*51转染靶细胞的杀伤更有效。此外,在这些克隆中,检测到KIR3DS1与NKG2D表面密度之间存在直接相关性,而NKp46的表达与KIR3DS1的表达呈负相关。最后,我们分析了来自携带细胞质KIR3DL1的HLA-B Bw4供体的KIR3DS1/NKG2A NK细胞克隆。尽管这些克隆表面KIR3DS1的表达水平较低,但它们表现出与源自表达表面KIR3DL1的HLA-B Bw4供体的NK细胞克隆相当的反应。总之,这些数据表明,在特定的KIR/HLA组合中,KIR3DS1可能在人类NK细胞的教育过程中发挥作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19bc/5445109/36d19e04f656/fimmu-08-00581-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19bc/5445109/7e2e311c2aba/fimmu-08-00581-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19bc/5445109/01690b33ddc2/fimmu-08-00581-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19bc/5445109/21179055d285/fimmu-08-00581-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19bc/5445109/5c486164a0c1/fimmu-08-00581-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19bc/5445109/bb29dcf7f0f4/fimmu-08-00581-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19bc/5445109/4308f40b62f4/fimmu-08-00581-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19bc/5445109/fc2260b830e8/fimmu-08-00581-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19bc/5445109/36d19e04f656/fimmu-08-00581-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19bc/5445109/7e2e311c2aba/fimmu-08-00581-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19bc/5445109/01690b33ddc2/fimmu-08-00581-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19bc/5445109/21179055d285/fimmu-08-00581-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19bc/5445109/5c486164a0c1/fimmu-08-00581-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19bc/5445109/bb29dcf7f0f4/fimmu-08-00581-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19bc/5445109/4308f40b62f4/fimmu-08-00581-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19bc/5445109/fc2260b830e8/fimmu-08-00581-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19bc/5445109/36d19e04f656/fimmu-08-00581-g008.jpg

相似文献

1
KIR3DS1-Mediated Recognition of HLA-*B51: Modulation of KIR3DS1 Responsiveness by Self HLA-B Allotypes and Effect on NK Cell Licensing.KIR3DS1介导的HLA-*B51识别:自身HLA-B同种异型对KIR3DS1反应性的调节及其对自然杀伤细胞许可的影响
Front Immunol. 2017 May 26;8:581. doi: 10.3389/fimmu.2017.00581. eCollection 2017.
2
Phenotypic and functional analyses of KIR3DL1+ and KIR3DS1+ NK cell subsets demonstrate differential regulation by Bw4 molecules and induced KIR3DS1 expression on stimulated NK cells.KIR3DL1+和KIR3DS1+自然杀伤(NK)细胞亚群的表型和功能分析表明,Bw4分子对其有不同的调控作用,并在受刺激的NK细胞上诱导KIR3DS1表达。
J Immunol. 2009 Jun 1;182(11):6727-35. doi: 10.4049/jimmunol.0900212.
3
Role of KIR3DS1 in human diseases.KIR3DS1 在人类疾病中的作用。
Front Immunol. 2012 Nov 1;3:326. doi: 10.3389/fimmu.2012.00326. eCollection 2012.
4
Functional polymorphism of the KIR3DL1/S1 receptor on human NK cells.人类自然杀伤细胞上KIR3DL1/S1受体的功能多态性
J Immunol. 2007 Jan 1;178(1):235-41. doi: 10.4049/jimmunol.178.1.235.
5
HLA-Bw4 80(T) and multiple HLA-Bw4 copies combined with KIR3DL1 associate with spontaneous clearance of HCV infection in people who inject drugs.HLA-Bw4 80(T) 等位基因和多个 HLA-Bw4 拷贝与 KIR3DL1 共同存在与静脉吸毒人群中自发性 HCV 感染清除相关。
J Hepatol. 2017 Sep;67(3):462-470. doi: 10.1016/j.jhep.2017.03.040. Epub 2017 Apr 13.
6
KIR3DS1/HLA-B Bw4-80Ile Genotype Is Correlated with the IFN-α Therapy Response in hepatitis B e antigen-Positive Chronic Hepatitis B.KIR3DS1/HLA-B Bw4-80Ile基因型与乙肝e抗原阳性慢性乙型肝炎患者的干扰素-α治疗反应相关。
Front Immunol. 2017 Oct 11;8:1285. doi: 10.3389/fimmu.2017.01285. eCollection 2017.
7
Donor KIR3DL1/3DS1 gene and recipient Bw4 KIR ligand as prognostic markers for outcome in unrelated hematopoietic stem cell transplantation.供体KIR3DL1/3DS1基因和受体Bw4 KIR配体作为非亲缘造血干细胞移植预后的标志物。
Biol Blood Marrow Transplant. 2009 Nov;15(11):1366-75. doi: 10.1016/j.bbmt.2009.06.015.
8
The impact of killer cell immunoglobulin-like receptor (KIR) genes and human leukocyte antigen (HLA) class I ligands on predisposition or protection against prostate cancer.杀伤细胞免疫球蛋白样受体(KIR)基因和人类白细胞抗原(HLA)I类配体对前列腺癌易感性或保护性的影响。
Immunobiology. 2023 Mar;228(2):152319. doi: 10.1016/j.imbio.2022.152319. Epub 2022 Dec 27.
9
Peptide-Dependent Recognition of HLA-B*57:01 by KIR3DS1.KIR3DS1对HLA - B*57:01的肽依赖性识别
J Virol. 2015 May;89(10):5213-21. doi: 10.1128/JVI.03586-14. Epub 2015 Mar 4.
10
Association of killer cell immunoglobulin-like receptors and their cognate HLA class I ligands with susceptibility to acute myeloid leukemia in Iranian patients.杀伤细胞免疫球蛋白样受体及其同源 HLA Ⅰ类配体与伊朗患者急性髓系白血病易感性的关系。
Sci Rep. 2023 Jul 15;13(1):11456. doi: 10.1038/s41598-023-38479-x.

引用本文的文献

1
HLA class I NK-epitopes and KIR diversities in patients with multiple myeloma.多发性骨髓瘤患者的 HLA I 类 NK 表位和 KIR 多样性。
Immunogenetics. 2024 Jun;76(3):155-164. doi: 10.1007/s00251-024-01336-w. Epub 2024 Mar 13.
2
Natural killer cells and their exosomes in viral infections and related therapeutic approaches: where are we?自然杀伤细胞及其细胞外囊泡在病毒感染及相关治疗方法中的作用:我们的研究进展如何?
Cell Commun Signal. 2023 Sep 25;21(1):261. doi: 10.1186/s12964-023-01266-2.
3
Contribution of natural killer cells in innate immunity against colorectal cancer.

本文引用的文献

1
HLA-F and MHC-I Open Conformers Bind Natural Killer Cell Ig-Like Receptor KIR3DS1.HLA-F和MHC-I开放构象体结合自然杀伤细胞免疫球蛋白样受体KIR3DS1。
PLoS One. 2016 Sep 20;11(9):e0163297. doi: 10.1371/journal.pone.0163297. eCollection 2016.
2
Open conformers of HLA-F are high-affinity ligands of the activating NK-cell receptor KIR3DS1.HLA - F的开放构象是激活型自然杀伤细胞受体KIR3DS1的高亲和力配体。
Nat Immunol. 2016 Sep;17(9):1067-74. doi: 10.1038/ni.3513. Epub 2016 Jul 25.
3
Killer cell immunoglobulin-like receptor 3DL1 polymorphism defines distinct hierarchies of HLA class I recognition.
自然杀伤细胞在针对结直肠癌的先天免疫中的作用。
Front Oncol. 2023 Jan 4;12:1077053. doi: 10.3389/fonc.2022.1077053. eCollection 2022.
4
KIR-HLA gene diversities and susceptibility to lung cancer.杀伤细胞免疫球蛋白样受体(KIR)-HLA 基因多样性与肺癌易感性。
Sci Rep. 2022 Oct 14;12(1):17237. doi: 10.1038/s41598-022-21062-1.
5
Characterization of KIR NK cell subsets with a monoclonal antibody selectively recognizing KIR2DL1 and blocking the specific interaction with HLA-C.用一种单克隆抗体特异性识别 KIR2DL1 并阻断其与 HLA-C 特异性相互作用来鉴定 KIRNK 细胞亚群。
HLA. 2022 Aug;100(2):119-132. doi: 10.1111/tan.14640. Epub 2022 May 15.
6
Epitope characterization of a monoclonal antibody that selectively recognizes KIR2DL1 allotypes.鉴定选择性识别 KIR2DL1 同种异型的单克隆抗体表位。
HLA. 2022 Aug;100(2):107-118. doi: 10.1111/tan.14630. Epub 2022 Jun 9.
7
Individualized Constellation of Killer Cell Immunoglobulin-Like Receptors and Cognate HLA Class I Ligands that Controls Natural Killer Cell Antiviral Immunity Predisposes COVID-19.控制自然杀伤细胞抗病毒免疫的杀伤细胞免疫球蛋白样受体和同源HLA I类配体的个体化组合易患COVID-19。
Front Genet. 2022 Feb 22;13:845474. doi: 10.3389/fgene.2022.845474. eCollection 2022.
8
Allele imputation for the killer cell immunoglobulin-like receptor KIR3DL1/S1.KIR3DL1/S1 杀伤细胞免疫球蛋白样受体的等位基因赋值。
PLoS Comput Biol. 2022 Feb 22;18(2):e1009059. doi: 10.1371/journal.pcbi.1009059. eCollection 2022 Feb.
9
Human NK cells, their receptors and function.人自然杀伤细胞、其受体和功能。
Eur J Immunol. 2021 Jul;51(7):1566-1579. doi: 10.1002/eji.202049028. Epub 2021 May 10.
10
Coexistence of inhibitory and activating killer-cell immunoglobulin-like receptors to the same cognate HLA-C2 and Bw4 ligands confer breast cancer risk.相同的 HLA-C2 和 Bw4 配体上抑制性和激活型杀伤细胞免疫球蛋白样受体的共存赋予乳腺癌风险。
Sci Rep. 2021 Apr 12;11(1):7932. doi: 10.1038/s41598-021-86964-y.
杀伤细胞免疫球蛋白样受体3DL1多态性定义了HLA I类识别的不同层次结构。
J Exp Med. 2016 May 2;213(5):791-807. doi: 10.1084/jem.20152023. Epub 2016 Apr 4.
4
Hematopoietic stem cell transplantation: Improving alloreactive Bw4 donor selection by genotyping codon 86 of KIR3DL1/S1.造血干细胞移植:通过对KIR3DL1/S1第86位密码子进行基因分型改善同种异体反应性Bw4供体选择。
Eur J Immunol. 2016 Jun;46(6):1511-7. doi: 10.1002/eji.201546236.
5
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces nonrelapse mortality.KIR 配体错配供者的单倍体造血移植伴有激活型 KIR 可降低非复发死亡率。
Blood. 2015 May 14;125(20):3173-82. doi: 10.1182/blood-2014-09-599993. Epub 2015 Mar 13.
6
Peptide-Dependent Recognition of HLA-B*57:01 by KIR3DS1.KIR3DS1对HLA - B*57:01的肽依赖性识别
J Virol. 2015 May;89(10):5213-21. doi: 10.1128/JVI.03586-14. Epub 2015 Mar 4.
7
Activating killer cell Ig-like receptors in health and disease.健康与疾病状态下激活杀伤细胞免疫球蛋白样受体
Front Immunol. 2014 Apr 22;5:184. doi: 10.3389/fimmu.2014.00184. eCollection 2014.
8
Decreased peripheral natural killer cells activity in the immune activated stage of chronic hepatitis B.慢性乙型肝炎免疫激活期外周自然杀伤细胞活性降低。
PLoS One. 2014 Feb 10;9(2):e86927. doi: 10.1371/journal.pone.0086927. eCollection 2014.
9
The speed of change: towards a discontinuity theory of immunity?变化的速度:走向免疫的不连续性理论?
Nat Rev Immunol. 2013 Oct;13(10):764-9. doi: 10.1038/nri3521. Epub 2013 Sep 2.
10
Influence of KIR gene copy number on natural killer cell education.KIR 基因拷贝数对自然杀伤细胞教育的影响。
Blood. 2013 Jun 6;121(23):4703-7. doi: 10.1182/blood-2012-10-461442. Epub 2013 May 1.